These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34787583)

  • 1. Long-Term Survival Among Histological Subtypes in Advanced Epithelial Ovarian Cancer: Population-Based Study Using the Surveillance, Epidemiology, and End Results Database.
    Yang SP; Su HL; Chen XB; Hua L; Chen JX; Hu M; Lei J; Wu SG; Zhou J
    JMIR Public Health Surveill; 2021 Nov; 7(11):e25976. PubMed ID: 34787583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
    Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
    Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
    Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
    J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer.
    Zhou J; Wu SG; Wang J; Sun JY; He ZY; Jin X; Zhang WW
    Front Oncol; 2018; 8():577. PubMed ID: 30564556
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.
    Mackay HJ; Brady MF; Oza AM; Reuss A; Pujade-Lauraine E; Swart AM; Siddiqui N; Colombo N; Bookman MA; Pfisterer J; du Bois A;
    Int J Gynecol Cancer; 2010 Aug; 20(6):945-52. PubMed ID: 20683400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary.
    Zhu Y; Meng F; Fang H; Zhang Z; Wang L; Zheng W
    Int J Gynecol Cancer; 2020 Feb; 30(2):207-212. PubMed ID: 31796530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
    Song BB; Anderson ZS; Masjedi AD; Lee MW; Mandelbaum RS; Klar M; Roman LD; Wright JD; Matsuo K
    Obstet Gynecol; 2024 Jul; 144(1):68-78. PubMed ID: 38781594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 12. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
    Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
    J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database.
    De Nonneville A; Zemmour C; Frank S; Joly F; Ray-Coquard I; Costaz H; Classe JM; Floquet A; De la Motte Rouge T; Colombo PE; Sauterey B; Leblanc E; Pomel C; Marchal F; Barranger E; Savoye AM; Guillemet C; Petit T; Pautier P; Rouzier R; Gladieff L; Simon G; Courtinard C; Sabatier R
    Gynecol Oncol; 2021 Oct; 163(1):64-71. PubMed ID: 34294414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of laterality on the incidence and prognosis of epithelial ovarian cancer.
    Zhang Y; Wu C; Huang Y; Kang J; Yao S; Chen Y; Gu L; Yang G
    Eur J Surg Oncol; 2024 Sep; 50(9):108475. PubMed ID: 38870872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in advanced epithelial ovarian cancer by histology: A SEER based survival analysis.
    Liu Y; Ni M; Huang F; Gu Q; Xiao Y; Du X
    Medicine (Baltimore); 2023 Jan; 102(4):e32774. PubMed ID: 36705377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
    Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
    Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological Characteristics and Early-Stage Diagnosis Are Associated With Better Survival in Young Patients With Epithelial Ovarian Cancer: A Retrospective Analysis Based on Surveillance Epidemiology and End Results Database.
    Huang Y; Ming X; Li B; Li Z
    Front Oncol; 2020; 10():595789. PubMed ID: 33425749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.